Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

29. Mai 2018 16:30 ET | Quelle: Cara Therapeutics, Inc.

Cara Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference

STAMFORD, Conn., May 29, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
23. Mai 2018 06:00 ET | Quelle: Cara Therapeutics, Inc.

Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) Enter into Ex-U.S. Licensing Agreement to Commercialize KORSUVA™ Injection in Dialysis Patients with Pruritus

Cara receives upfront payment of $50 million in cash and an equity investment of $20 million Cara eligible for up to $470 million in regulatory and commercial milestones VFMCRP to commercialize...
14. Mai 2018 16:01 ET | Quelle: Cara Therapeutics, Inc.

Cara Therapeutics to Present at the International Investigative Dermatology 2018 Meeting

STAMFORD, Conn., May 14, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
09. Mai 2018 16:01 ET | Quelle: Cara Therapeutics, Inc.

Cara Therapeutics Reports First Quarter 2018 Financial Results

STAMFORD, Conn., May 09, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
02. Mai 2018 16:30 ET | Quelle: Cara Therapeutics, Inc.

Cara Therapeutics to Announce First Quarter 2018 Financial Results on May 9, 2018

STAMFORD, Conn., May 02, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
10. April 2018 07:00 ET | Quelle: Cara Therapeutics, Inc.

Cara Therapeutics Announces Participation in 2018 Spring Clinical Meetings of the National Kidney Foundation

STAMFORD, Conn., April 10, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
15. März 2018 16:01 ET | Quelle: Cara Therapeutics, Inc.

Cara Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

STAMFORD, Conn., March 15, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to...
08. März 2018 16:30 ET | Quelle: Cara Therapeutics, Inc.

Cara Therapeutics to Announce Fourth Quarter and Full Year 2017 Financial Results on March 15, 2018

STAMFORD, Conn., March 08, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
28. Februar 2018 07:00 ET | Quelle: Cara Therapeutics, Inc.

Cara Therapeutics Doses First Patient in Phase 1 Trial of Oral KORSUVA™ (CR845/difelikefalin) in Chronic Liver Disease (CLD) Patients

STAMFORD, Conn., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
07. Februar 2018 16:01 ET | Quelle: Cara Therapeutics, Inc.

Cara Therapeutics to Present at the Leerink Partners 7th Annual Global Healthcare Conference

STAMFORD, Conn., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...

Vorherige Seite